FNFlora Nolent

Flora Nolent

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Flora Nolent has a total of 162 co-authors. Here are the top co-authors by number of shared publications:

  • Jérome Maluenda

    Institut National de la Santé et de la Recherche Médicale (Inserm) UMR-1169, Université Paris Sud, Le Kremlin Bicêtre 94276, France

    5 shared publications
  • Judith Melki

    Institut National de la Santé et de la Recherche Médicale (INSERM), UMR 1195, Université Paris Saclay, Le Kremlin Bicêtre, France

    4 shared publications
  • Annie Laquerrière

    Pathology Laboratory and NeoVasc Region-INSERM Team ERI28, Institute of Research for Innovation in Biomedicine, University of Rouen, Rouen, 76031, France

    3 shared publications
  • Gianina Ravenscroft

    Harry Perkins Institute of Medical Research, Centre for Medical Research, University of Western Australia, Nedlands, WA 6009, Australia

    3 shared publications
  • Ivo Gut

    Centro Nacional de Análisis Genómico, Barcelona, 080028, Spain

    3 shared publications
  • Marc Drolet

    Département de microbiologie, infectiologie et immunologie, Université de Montréal, C.P. 6128, Succ. Centre-ville, Montréal, P. Québec, H3C 3J7, Canada

    3 shared publications

Latest Publications

  • Truncating Mutations of MAGEL2, a Gene within the Prader-Willi Locus, Are Responsible for Severe Arthrogryposis

    by Dan Mejlachowicz, Flora Nolent, Jérome Maluenda, Hanitra Ranjatoelina-Randrianaivo, Fabienne Giuliano, Ivo Gut, Damien Sternberg, Annie Laquerrière, Judith Melki


  • Mutations of GPR126 Are Responsible for Severe Arthrogryposis Multiplex Congenita

    by Gianina Ravenscroft, Flora Nolent, Sulekha Rajagopalan, Ana M. Meireles, Kevin J. Paavola, Dominique Gaillard, Elisabeth Alanio, Michael Buckland, Susan Arbuckle, Michael Krivanek, et al.


  • Open Access

    Leiomodin-3 dysfunction results in thin filament disorganization and nemaline myopathy

    by Michaela Yuen, Sarah A. Sandaradura, James J. Dowling, Alla S. Kostyukova, Natalia Moroz, Kate G. Quinlan, Vilma-Lotta Lehtokari, Gianina Ravenscroft, Emily J. Todd, Ozge Ceyhan-Birsoy, et al.


  • Open Access

    Leiomodin-3 dysfunction results in thin filament disorganization and nemaline myopathy

    by Michaela Yuen, Sarah A. Sandaradura, James J. Dowling, Alla S. Kostyukova, Natalia Moroz, Kate G. Quinlan, Vilma-Lotta Lehtokari, Gianina Ravenscroft, Emily J. Todd, Ozge Ceyhan-Birsoy, et al.

    Nemaline myopathy (NM) is a genetic muscle disorder characterized by muscle dysfunction and electron-dense protein accumulations (nemaline bodies) in myofibers. Pathogenic mutations have been described in 9 genes to date, but the genetic basis remains unknown in many cases. Here, using an approach that combined whole-exome sequencing (WES) and Sanger sequencing, we identified homozygous or compound heterozygous variants in LMOD3 in 21 patients from 14 families with severe, usually lethal, NM. LMOD3 encodes leiomodin-3 (LMOD3), a 65-kDa protein expressed in skeletal and cardiac muscle. LMOD3 was expressed from early stages of muscle differentiation; localized to actin thin filaments, with enrichment near the pointed ends; and had strong actin filament-nucleating activity. Loss of LMOD3 in patient muscle resulted in shortening and disorganization of thin filaments. Knockdown of lmod3 in zebrafish replicated NM-associated functional and pathological phenotypes. Together, these findings indicate that mutations in the gene encoding LMOD3 underlie congenital myopathy and demonstrate that LMOD3 is essential for the organization of sarcomeric thin filaments in skeletal muscle.


  • Open Access

    Mutations in CNTNAP1 and ADCY6 are responsible for severe arthrogryposis multiplex congenita with axoglial defects

    by Annie Laquérriere, Jérome Maluenda, Adrien Camus, Laura Fontenas, Klaus Dieterich, Flora Nolent, Jié Zhou, Nicole Monnier, Philippe Latour, Damien Gentil, et al.

    Non-syndromic arthrogryposis multiplex congenita (AMC) is characterized by multiple congenital contractures resulting from reduced fetal mobility. Genetic mapping and whole exome sequencing (WES) were performed in 31 multiplex and/or consanguineous undiagnosed AMC families. Although this approach identified known AMC genes, we here report pathogenic mutations in two new genes. Homozygous frameshift mutations in CNTNAP1 were found in four unrelated families. Patients showed a marked reduction in motor nerve conduction velocity (CNTNAP1 encodes CASPR, an essential component of node of Ranvier domains which underlies saltatory conduction of action potentials along the myelinated axons, an important process for neuronal function. A homozygous missense mutation in adenylate cyclase 6 gene (ADCY6) was found in another family characterized by a lack of myelin in the peripheral nervous system (PNS) as determined by TEM. Morpholino knockdown of the zebrafish orthologs led to severe and specific defects in peripheral myelin in spite of the presence of Schwann cells. ADCY6 encodes a protein that belongs to the adenylate cyclase family responsible for the synthesis of cAMP. Elevation of cAMP can mimic axonal contact in vitro and upregulates myelinating signals. Our data indicate an essential and so far unknown role of ADCY6 in PNS myelination likely through the cAMP pathway. Mutations of genes encoding proteins of Ranvier domains or involved in myelination of Schwann cells are responsible for novel and severe human axoglial diseases.


  • Interplay between Type 1A Topoisomerases and Gyrase in Chromosome Segregation in Escherichia coli

    by Valentine Usongo, Cynthia Tanguay, Flora Nolent, Jill Egbe Bessong, Marc Drolet

    Escherichia coli possesses two type 1A topoisomerases, Topo I ( topA ) and Topo III ( topB ). Topo I relaxes excess negative supercoiling, and topA mutants can grow only in the presence of compensatory mechanisms, such as gyrase mutations. topB mutants grow as well as wild-type cells. In vitro , Topo III, but not Topo I, can efficiently decatenate DNA during replication. However, in vivo , a chromosome segregation defect is seen only when both type 1A topoisomerases are absent. Here we present experimental evidence for an interplay between gyrase and type 1A topoisomerases in chromosome segregation. We found that both the growth defect and the Par − phenotypes of a gyrB (Ts) mutant at nonpermissive temperatures were significantly corrected by deleting topA , but only when topB was present. Overproducing Topo IV, the major cellular decatenase, could not substitute for topB . We also show that overproducing Topo III at a very high level could suppress the Par − phenotype. We previously found that the growth and chromosome segregation defects of a triple topA rnhA gyrB (Ts) mutant in which gyrase supercoiling activity was strongly inhibited could be corrected by overproducing Topo III (V. Usongo, F. Nolent, P. Sanscartier, C. Tanguay, S. Broccoli, I. Baaklini, K. Drlica, and M. Drolet, Mol. Microbiol. 69: 968-981, 2008). We show here that this overproduction could be bypassed by substituting the gyrB (Ts) allele for a gyrB + one or by growing cells in a minimal medium, conditions that reduced both topA - and rnhA -dependent unregulated replication. Altogether, our data point to a role for Topo III in chromosome segregation when gyrase is inefficient and suggest that Topo I plays an indirect role via supercoiling regulation.


  • Spinal Muscular Atrophy Associated with Progressive Myoclonic Epilepsy Is Caused by Mutations in ASAH1

    by Jie Zhou, Marcel Tawk, Francesco Danilo Tiziano, Julien Veillet, Monica Bayes, Flora Nolent, Virginie Garcia, Serenella Servidei, Enrico Bertini, Francesc Castro-Giner, et al.


  • Hypernegative Supercoiling Inhibits Growth by Causing RNA Degradation

    by Imad Baaklini, Valentine Usongo, Flora Nolent, Patrick Sanscartier, Chadi Hraiky, Karl Drlica, Marc Drolet

    Transcription-induced hypernegative supercoiling is a hallmark ofEscherichia colitopoisomerase I (topA) mutants. However, its physiological significance has remained unclear. Temperature downshift of a mutant yielded transient growth arrest and a parallel increase in hypernegative supercoiling that was more severe with lower temperature. Both properties were alleviated by overexpression of RNase HI. While ribosomes in extracts showed normal activity when obtained during growth arrest, mRNA on ribosomes was reduced forfisand shorter forcrp, polysomes were much less abundant relative to monosomes, and protein synthesis rate dropped, as did the ratio of large to small proteins. Altered processing and degradation oflacAandfismRNA was also observed. These data are consistent with truncation of mRNA during growth arrest. These effects were not affected by a mutation in the gene encoding RNase E, indicating that this endonuclease is not involved in the abnormal mRNA processing. They were also unaffected by spectinomycin, an inhibitor of protein synthesis, which argued against induction of RNase activity. In vitro transcription revealed that R-loop formation is more extensive on hypernegatively supercoiled templates. These results allow us, for the first time, to present a model by which hypernegative supercoiling inhibits growth. In this model, the introduction of hypernegative supercoiling by gyrase facilitates degradation of nascent RNA; overproduction of RNase HI limits the accumulation of hypernegative supercoiling, thereby preventing extensive RNA degradation.


  • Open Access

    Depletion of RNase HI activity in Escherichia coli lacking DNA topoisomerase I leads to defects in DNA supercoiling and segregation

    by Valentine Usongo, Flora Nolent, Patrick Sanscartier, Cynthia Tanguay, Sonia Broccoli, Imad Baaklini, Karl Drlica, Marc Drolet

    Summary: Gyrase‐mediated hypernegative supercoiling is one manifestation of R‐loop formation, a phenomenon that is normally suppressed by topoisomerase I (topA) in Escherichia coli. Overproduction of RNase HI (rnhA), an enzyme that removes the RNA moiety of R‐loops, prevents hypernegative supercoiling and allows growth of topA null mutants. We previously showed that topA and rnhA null mutations are incompatible. We now report that such mutants were viable when RNase HI or topoisomerase III was expressed from a plasmid‐borne gene. Surprisingly, DNA of topA null mutants became relaxed rather than hypernegatively supercoiled following depletion of RNase HI activity. This result failed to correlate with the cellular concentration of gyrase or topoisomerase IV (the other relaxing enzyme in the cell) or with transcription‐induced supercoiling. Rather, intracellular DNA relaxation in the absence of RNase HI was related to inhibition of gyrase activity both in vivo and in extracts. Cells lacking topA and rnhA also exhibited properties consistent with segregation defects. Overproduction of topoisomerase III, an enzyme that can carry out DNA decatenation, corrected the segregation defects without restoring supercoiling activity. Collectively these data reveal (i) the existence of a cellular response to loss of RNase HI that counters the supercoiling activity of gyrase, and (ii) supercoiling‐independent segregation defects due to loss of RNase HI from topA null mutants. Thus RNase HI plays a more central role in DNA topology than previously thought.